Question follow-through · 36556
Rare Diseases: Medical Treatments
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the proposed changes to National Institute for Health and Care Excellence Highly Specialised Technology (HST) routing criteria aligns with the stated aim of HST to
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 7 Mar 2025
- Target answer date
- 11 Mar 2025
- Answer
- 13 Mar 2025 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Myasthenia Gravis: Medical Treatments · 11 Mar 2025
- Myasthenia Gravis: Medical Treatments · 11 Mar 2025
- Rare Diseases: Diagnosis and Medical Treatments · 11 Mar 2025
- Care Homes: Drugs · 30 Apr 2025
- Care Homes: Drugs · 30 Apr 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
7 Mar 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the proposed changes to National Institute for Health and Care Excellence Highly Specialised Technology (HST) routing criteria aligns with the stated aim of HST to
11 Mar 2025
Target answer date
Date supplied by the official written-questions record.
13 Mar 2025
Answer published
Decisions on whether medicines should be evaluated by the National Institute for Health and Care Excellence (NICE) through its highly specialised technologies (HST) programme are taken by NICE itself against a set of published criteria that have been deve...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Myasthenia Gravis: Medical Treatments
11 Mar 2025 · To ask the Secretary of State for Health and Social Care, what steps he has taken to increase patient access to new and innovative treatments for Myasthenia Gravis.
Myasthenia Gravis: Medical Treatments
11 Mar 2025 · To ask the Secretary of State for Health and Social Care, what his planned timetable is for when patients with Myasthenia Gravis will have access to recently licenced products.
Rare Diseases: Diagnosis and Medical Treatments
11 Mar 2025 · To ask the Secretary of State for Health and Social Care, whether the NHS 10 Year Plan will include steps to ensure healthcare professionals are adequately trained and supported in diagnosing and treating rare diseases like Myasthenia Gravis.
Care Homes: Drugs
30 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made on the adequacy of access to (a) medicines and (b) controlled drugs in care homes in North Somerset.
Care Homes: Drugs
30 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of regulation of access to controlled drugs in care homes in North Somerset.
Health Services
12 May 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to include policies on self-care within the forthcoming 10-year Health Plan.
NHS England: Drugs
22 May 2025 · To ask the Secretary of State for Health and Social Care, how many commercial agreements NHS England has made with manufacturers of medicines which have r resulted in indication-specific pricing between January 2020 and March 2025; and what therapeutic ar
Life Sciences
22 May 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NHS England’s criterion for eligibility for indication-specific pricing to demonstrate revenue loss on the UK’s international competitiveness
Health Services
3 Jun 2025 · To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 16 May 2025 to Question 51728, what steps he is taking to ensure that patients (a) improve and (b) protect their own health.
Pharmacy: Fees and Charges
3 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to prevent spoke pharmacies from charging patients for additional services which are delivered by an outsourced hub partner.
Nurses: Schools
10 Jun 2025 · To ask the Secretary of State for Health and Social Care, how many and what proportion of school nurses have received specialist training in (a) allergy and (b) anaphylaxis management.
Bladder Cancer: Health Services
23 Jun 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of care for bladder cancer in each region; and if he will hold discussions with NICE guidelines on the time taken to update its guidelines on